Clinical Trial: oHSV2-PD-L1/CD3-BsAb Administered Via Intramural Injection
Study Status: Completed
Recruit Status: RECRUITING
Condition: Solid Tumor
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label Study of BS006, an Oncolytic Virus, Administered by Intratumoral Injection in Patients With Advanced/Metastatic Solid Tumors
Brief Summary:
This study will be a Phase 1, multi-center, open-label, dose escalation followed by the recommended phase 2 dose (RP2D) expansion study to characterize safety, tolerability, biodistribution, virus shedding and preliminary efficacy of intratumoral injection of BS006 in patients with advanced solid tumors.
Read more